{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:55:45Z","timestamp":1782266145740,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jdermsci.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T17:08:12Z","timestamp":1425920892000},"page":"5-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?"],"prefix":"10.1016","volume":"78","author":[{"given":"Hideyuki","family":"Ujiie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2015.03.002_bib0295","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1172\/JCI114036","article-title":"Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases","volume":"83","author":"Stanley","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0300","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jdermsci.2013.12.001","article-title":"Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII","volume":"73","author":"Nishie","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0310","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"Sardy","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0315","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0320","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0325","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0330","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12026-014-8547-7","article-title":"Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid","volume":"59","author":"Messingham","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0335","doi-asserted-by":"crossref","first-page":"e107725","DOI":"10.1371\/journal.pone.0107725","article-title":"Human eosinophils express the high affinity IgE receptor, FcepsilonRI, in bullous pemphigoid","volume":"9","author":"Messingham","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0340","first-page":"352","article-title":"Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa","volume":"60","author":"Gatalica","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0345","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0945-053X(03)00051-9","article-title":"Collagenous transmembrane proteins: collagen XVII as a prototype","volume":"22","author":"Franzke","year":"2003","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0350","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0355","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0360","first-page":"577","article-title":"IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity","volume":"42","author":"Dopp","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2222.1999.0290s3109.x","article-title":"Assessment of urticaria and angio-oedema","volume":"29","author":"Friedmann","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0370","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1346-8138.2011.01388.x","article-title":"Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years","volume":"39","author":"Ikeda","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2015.02.009","article-title":"Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid","volume":"78","author":"Kamiya","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","article-title":"In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases","volume":"78","author":"Moriuchi","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0385","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jdermsci.2015.02.015","article-title":"Circulating IgE auti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients","volume":"78","author":"Ma","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/1523-1747.ep12505711","article-title":"Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient","volume":"78","author":"Dvorak","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0395","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI11494","article-title":"Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0400","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nri2072","article-title":"New developments in FcepsilonRI regulation, function and inhibition","volume":"7","author":"Kraft","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0405","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.4049\/jimmunol.157.8.3642","article-title":"IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid","volume":"157","author":"Delaporte","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0410","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.2003.12146.x","article-title":"Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid","volume":"120","author":"Dimson","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0415","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2340\/0001555564243246","article-title":"Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies","volume":"64","author":"Asbrink","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s004030050272","article-title":"IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity","volume":"290","author":"D\u2019Auria","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0425","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","article-title":"Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid","volume":"144","author":"Iwata","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0430","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","article-title":"Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid","volume":"49","author":"Ishiura","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0435","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","article-title":"A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid","volume":"346","author":"Messingham","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0440","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2133.1992.tb11833.x","article-title":"Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoid","volume":"126","author":"Parodi","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0445","first-page":"193","article-title":"Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin","volume":"18","author":"Provost","year":"1974","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0450","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","article-title":"Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis","volume":"165","author":"Yayli","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0455","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0460","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0465","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0470","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0475","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.1100596","article-title":"Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice","volume":"187","author":"Hirose","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0480","article-title":"Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice","author":"Hurskainen","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0485","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.immunol.21.120601.141103","article-title":"The biology of IGE and the basis of allergic disease","volume":"21","author":"Gould","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0490","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0495","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2133.1998.02169.x","article-title":"Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity","volume":"138","author":"Ameglio","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0500","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF02507102","article-title":"Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid","volume":"288","author":"Schmidt","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0505","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1365-2133.2000.03599.x","article-title":"Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia","volume":"143","author":"Wakugawa","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0510","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.0022-202x.2001.01505.x","article-title":"Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells","volume":"117","author":"Teraki","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0515","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-4632.2006.02861.x","article-title":"Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?","volume":"45","author":"Wilczek","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0520","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.4049\/jimmunol.1001524","article-title":"Ectodomain shedding generates neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid","volume":"185","author":"Nishie","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0525","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0530","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0535","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.4049\/jimmunol.1003402","article-title":"Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner","volume":"188","author":"Natsuga","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0540","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0545","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0550","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1164\/ajrccm.164.supplement_1.2103025","article-title":"Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders","volume":"164","author":"Schulman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0555","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaci.2007.11.026","article-title":"Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy","volume":"121","author":"Corren","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0560","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2003.11.044","article-title":"Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils","volume":"113","author":"Lin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0565","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2133.2011.10748.x","article-title":"Successful management of severe infant bullous pemphigoid with omalizumab","volume":"166","author":"Dufour","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0570","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archdermatol.2012.1604","article-title":"Successful treatment of bullous pemphigoid with omalizumab","volume":"148","author":"London","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0575","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7754\/Clin.Lab.2013.130642","article-title":"Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200","volume":"60","author":"Yalcin","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.jdermsci.2015.03.002_bib0580","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","article-title":"Omalizumab therapy for bullous pemphigoid","volume":"71","author":"Yu","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092318111500078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092318111500078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T18:13:22Z","timestamp":1717784002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092318111500078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S092318111500078X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2015.03.002","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}